Intellipharmaceutics International Inc. (IPCI)

[fred198484]

The chances of an offering have to be low given the price of the stock. But they have to be high given the lack of cash. For IPCI, however, no cash is the norm and they seem to know how to get by. With revenues now flowing in due to Seroquel and Focalin sales, management likely feel things are better than they have ever been.

My best guess is there will not be any offerings until the share price is much higher. It could get much higher based on a possible partnership deal on Regbatin which the company has said it is looking to accomplish, a partnership deal with Rexista (I don't think the negative ADCOM results will prevent this since the panel so clearly lost its way and all knowledgeable parties know the drug is the best option for the patients) or new generics are soon approved/partnered (if not partnered already).

But if any of these things happen and the share price rebounds, I certainly expect a share offering. But it would have to recover a lot - I would think to at least $4 -$5 per share before any offering would be pursued. I could easily see how a Regbatin partnership alone could instantly change the whole complexion of the company in the eyes of investors and push the stock to the $4 - $5 range. Rexista's potential is impressive but Regbatin is even bigger.

I don't see them partnering PODRAS.